Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Vernakalant – Cardiology MCQ
No Comments | Aug 2, 2013 -
Metabolic syndrome – Cardiology MCQ
No Comments | Sep 1, 2013 -
Natriuretic peptides – Cardiology MCQ
No Comments | Oct 17, 2017 -
Syncope in valvular heart disease – Cardiology MCQ
No Comments | Oct 29, 2013
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal